MicroPort CardioFlow Medtech Corporation (2160.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap2.98B
Enterprise Value4.24B
P/E Ratio-0.81
PEG Ratio0
Price/Sales Ratio1.42
Price/Book Ratio0.06
Enterprise/Revenue0.74
Enterprise/EBITDA-44.49

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.35
Operating Margin-0.29
AD

Management Effectiveness

Return On Assets-0.2
Return On Equity-0.07

Income Statement

Revenue443.79M
Revenue/Share4.25
Gross Profit288.34M
EBITDA-111.57M
Net Income-146.41M
Diluted EPS-0.3

Balance Sheet

Total Cash1.38B
Total Cash/Share14.04
Total Debt258.36M
Total Debt/Equity0.13
Current Ratio2.53
Book Value Per Share2.9

Price History

52-Week Change-71.53
52-Week High8.45
52-Week Low1.09
Moving Average 50 Days2.14
Moving Average 200 Days4.44

Statistics

Average Volume1.37M
Shares Outstanding491.76M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:5
Last Split DateFebruary 24, 2026
AD